ViaDerma, Inc.
VDRM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $150 | $150 | $150 | $150 |
| % Growth | 0% | -0.2% | 0.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $150 | $150 | $150 | $150 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $445 | $165 | $45 | $92 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $445 | $165 | $45 | $92 |
| Operating Income | -$294 | -$15 | $106 | $58 |
| % Margin | -196.1% | -10% | 70.3% | 38.6% |
| Other Income/Exp. Net | -$27 | -$18 | -$18 | -$18 |
| Pre-Tax Income | -$322 | -$33 | $88 | $40 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$322 | -$33 | $88 | $40 |
| % Margin | -214.1% | -22.1% | 58.2% | 26.5% |
| EPS | -0 | 0 | 0 | 0 |
| % Growth | – | -100% | – | – |
| EPS Diluted | -0 | 0 | 0 | 0 |
| Weighted Avg Shares Out | 1,233,713 | 1,233,713 | 1,233,713 | 1,233,713 |
| Weighted Avg Shares Out Dil | 1,233,713 | 1,233,713 | 1,747,574 | 1,233,713 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $27 | $18 | $18 | $18 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$294 | -$15 | $106 | $58 |
| % Margin | -196% | -10% | 70.3% | 38.7% |